Wealth Alliance’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$220K Sell
3,500
-132
-4% -$10.6K 0.02% 518
2025
Q4
$346K Sell
3,632
-31
-0.8% -$3.04K 0.03% 398
2025
Q3
$358K Buy
3,663
+1,384
+61% +$143K 0.04% 375
2025
Q2
$245K Buy
2,279
+37
+2% +$3.74K 0.03% 473
2025
Q1
$226K Sell
2,242
-657
-23% -$66.2K 0.03% 472
2024
Q4
$259K Sell
2,899
-173
-6% -$15.2K 0.03% 420
2024
Q3
$257K Sell
3,072
-843
-22% -$66.5K 0.03% 437
2024
Q2
$301K Sell
3,915
-521
-12% -$38.1K 0.04% 381
2024
Q1
$304K Sell
4,436
-123
-3% -$7.91K 0.04% 397
2023
Q4
$264K Sell
4,559
-154
-3% -$8.22K 0.04% 420
2023
Q3
$249K Sell
4,713
-126
-3% -$6.61K 0.04% 406
2023
Q2
$262K Buy
4,839
+325
+7% +$17K 0.04% 421
2023
Q1
$226K Buy
+4,514
New +$213K 0.04% 441

Other funds holding BSX

Wealth Alliance's BSX Position: Q1 2026 in Review

Wealth Alliance reduced its Boston Scientific (BSX) stake by 3.6% in Q1 2026, selling an estimated $10.6K and leaving 3,500 shares worth $220K. The position accounts for 0.02% of the portfolio, ranked #518.

Wealth Alliance first reported a position in BSX in Q1 2023 and has held it in 13 quarters since. The position peaked at $358K in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Wealth Alliance held 3,500 shares of Boston Scientific worth $220K as of Q1 2026.
  • Wealth Alliance sold 132 Boston Scientific shares in Q1 2026, an estimated $10.6K.
  • Boston Scientific made up 0.02% of Wealth Alliance's portfolio in Q1 2026, its #518 holding.
  • Wealth Alliance first reported a position in Boston Scientific in Q1 2023 and has held it in 13 quarters since.
  • Wealth Alliance's Boston Scientific position peaked at $358K in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.